Literature DB >> 9783772

Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature.

B Grimbacher1, M Huber, J von Kempis, P Kalden, M Uhl, G Köhler, H E Blum, H H Peter.   

Abstract

Gastrointestinal vasculitis in systemic lupus erythematosus (SLE) is quite rare and almost always accompanied by evidence of active disease in other organs, although occasionally it may be the presenting feature of the disease. Gastrointestinal involvement in SLE may present as lupus peritonitis, non-necrotizing pancreatitis, gastrointestinal vasculitis or surgical abdomen. Here we report a severe case of SLE which presented initially with fever of unknown origin. Severe distress, abdominal pain, the presence of occult blood in the stool and high acute-phase proteins were explained by a lupus peritonitis and intestinal vasculitis resembling inflammatory bowel disease. Whereas high-dose prednisone treatment did not prevent a severe relapse, we observed a sustained remission following i.v. cyclophosphamide pulse therapy. In the literature, only two similar cases are reported: one died despite a change in the therapy of a bowel perforation; our case was the second that improved under pulse cyclophosphamide. We suggest the use of cyclophosphamide after failure of steroids early in the course of SLE gastrointestinal vasculitis to prevent devastating complications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783772     DOI: 10.1093/rheumatology/37.9.1023

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  14 in total

1.  Systemic vasculitis presenting with acute gastrointestinal hemorrhage: case report and review of the literature.

Authors:  Chad M Sisk; Chris Parker; Tim Cassidy; Allan Parker
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

2.  Acute abdominal pain in systemic lupus erythematosus: factors contributing to recurrence of lupus enteritis.

Authors:  Y G Kim; H K Ha; S S Nah; C-K Lee; H-B Moon; B Yoo
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

3.  A case of systemic lupus erythematosus complicated by alveolar hemorrhage and cytomegalovirus colitis.

Authors:  Masami Takei; Kenji Yamakami; Ko Mitamura; Noboru Kitamura; Yoshihiro Matsukawa; Shigemasa Sawada
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

4.  A unique case of systemic lupus erythematosus.

Authors:  Muhammad Khizar Rafiq
Journal:  BMJ Case Rep       Date:  2009-03-17

5.  Mesenteric vasculitis in children with systemic lupus erythematosus.

Authors:  Lampros Fotis; Kevin W Baszis; Anthony R French; Megan A Cooper; Andrew J White
Journal:  Clin Rheumatol       Date:  2015-02-17       Impact factor: 2.980

6.  Dramatic development of severe SLE in a patient with an incomplete disease.

Authors:  G Fabio; M Carrabba; C Hu; M Floriani; C Besana
Journal:  Rheumatol Int       Date:  2005-01-21       Impact factor: 2.631

7.  Ischemic colitis associated with intestinal vasculitis: histological proof in systemic lupus erythematosus.

Authors:  Jeong-Rok Lee; Chang-Nyol Paik; Jin-Dong Kim; Woo-Chul Chung; Kang-Moon Lee; Jin-Mo Yang
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

8.  Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis.

Authors:  Yuko Kaneko; Michito Hirakata; Akira Suwa; Shinji Satoh; Takaki Nojima; Yasuo Ikeda; Tsuneyo Mimori
Journal:  Clin Rheumatol       Date:  2004-05-15       Impact factor: 2.980

9.  Mesenteric vasculitis in a systemic lupus erythematosus patient with a low sledai: an uncommon presentation.

Authors:  Jozélio Freire de Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

10.  The use of tacrolimus for recurrent lupus enteritis: a case report.

Authors:  Tsuyoshi Shirai; Yasuhiko Hirabayashi; Ryu Watanabe; Yumi Tajima; Hiroshi Fujii; Naruhiko Takasawa; Tomonori Ishii; Hideo Harigae
Journal:  J Med Case Rep       Date:  2010-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.